Sector
PharmaceuticalsOpen
₹524.1Prev. Close
₹525.6Turnover(Lac.)
₹33.91Day's High
₹528.3Day's Low
₹518.0552 Week's High
₹615.6552 Week's Low
₹376.25Book Value
₹325.91Face Value
₹2Mkt Cap (₹ Cr.)
3,704.4P/E
0EPS
0Divi. Yield
09 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
23 Aug 2023
12:00 AM
AGM
Announcement Date: 23 Aug, 2023
According to the corporation, the observations have no influence on business continuity or supplies to the US market.
Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 14.08 | 14.08 | 14.08 | 14.08 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,280.54 | 2,370.19 | 2,657.96 | 2,683.25 |
Net Worth | 2,294.62 | 2,384.27 | 2,672.04 | 2,697.33 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 942.92 | 1,123.97 | 904.88 | 669.33 |
yoy growth (%) | -16.1 | 24.21 | 35.19 | 16.19 |
Raw materials | -383.47 | -432.94 | -382.75 | -350.68 |
As % of sales | 40.66 | 38.51 | 42.29 | 52.39 |
Employee costs | -250.79 | -234.03 | -205.15 | -146.53 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -86.74 | 65.64 | -63.81 | -121.55 |
Depreciation | -83.18 | -75.89 | -71.08 | -45.04 |
Tax paid | 31.31 | -11.56 | 7.49 | 0.14 |
Working capital | 139.57 | -55.07 | -268.15 | 642.72 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -16.1 | 24.21 | 35.19 | 16.19 |
Op profit growth | -145.62 | -205.35 | -33.48 | 134.8 |
EBIT growth | -226.48 | -207.06 | -47.18 | 31.19 |
Net profit growth | -202.49 | -196.03 | -102.2 | 2,361.41 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 1,704.89 | 1,343.02 | 1,269.83 | 1,235.14 | 1,103.71 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,704.89 | 1,343.02 | 1,269.83 | 1,235.14 | 1,103.71 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 31.6 | 38.52 | 47.51 | 50.19 | 92.13 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,587.35 | 124.83 | 3,80,990.4 | 867.6 | 0.85 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,534.8 | 76.42 | 1,20,383.36 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,490 | 32.38 | 1,20,295.96 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,154.55 | 33.79 | 1,16,159.65 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,770.9 | 26.36 | 1,12,931.2 | 1,034.8 | 0.59 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Non Exe. Director
Prafull Anubhai
Independent Non Exe. Director
Anand Mahajan
Independent Non Exe. Director
Prafull D Sheth
Independent Non Exe. Director
Priti Puri
Non-Exec & Non-Independent Dir
Pranay Godha
Managing Director
Pabitra Bhattacharya
Company Sec. & Compli. Officer
Pradeep Bhandari
Chairman (Non-Executive)
Prakash A Mody
Independent Director
Anand T Kusre
Independent Director
Arun Todarwal
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Unichem Laboratories Ltd
Summary
Unichem Laboratories Ltd is an India-based pharmaceutical company, which manufactures active pharmaceutical ingredients. The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division. The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh.The companys facilities enjoy credible certifications, the Goa plant was approved by UK MHRA, MCC (South Africa), WHO (Geneva) and TGA (Australia). The Baddi plant was approved by UK MHRA and MCC (South Africa). The company received ISO 9001:2000 for all their plants and corporate office. Also, they received ISO 14001:2004 certificates for their formulation plants located at Goa, Ghaziabad and Baddi and the corporate office at Mumbai.Unichem Laboratories Ltd was incorporated in the year 1962. The company was formed by Amrut V Mody to take over a proprietary business set up in 1944 in Mumbai. They made a foreign collaboration with UCB for bulk drugs and set up first formulation plant at Jogeshwari. In the year 1963, they made a tie up with Uni Sankyo Co-Marketing formulations.In the year 1968, the company set up formulations plant Ghaziabad and in the year 1976, they set up a fine chemicals unit at Roha. In the year 1984, the company entered an agreement with Upjohn and set up Unisearch Ltd. Also, they entered into
Read More
What is the Unichem Laboratories Ltd share price today?
The Unichem Laboratories Ltd shares price on N/A is Rs.₹524.5 today.
What is the Market Cap of Unichem Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Unichem Laboratories Ltd is ₹3692.78 Cr. as of 23 Jul ‘24
What is the PE and PB ratio of Unichem Laboratories Ltd?
The PE and PB ratios of Unichem Laboratories Ltd is 0 and 1.61 as of 23 Jul ‘24
What is the 52 Week High and Low of Unichem Laboratories Ltd?
The 52-week high/low is the highest and lowest price at which a Unichem Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Unichem Laboratories Ltd is ₹376 and ₹616 as of 23 Jul ‘24
What is the CAGR of Unichem Laboratories Ltd?
Unichem Laboratories Ltd's CAGR for 5 Years at 24.08%, 3 Years at 16.12%, 1 Year at 38.24%, 6 Month at 18.06%, 3 Month at -11.02% and 1 Month at -1.10%.
What is the shareholding pattern of Unichem Laboratories Ltd?
The shareholding pattern of Unichem Laboratories Ltd is as follows:
Promoters - 70.22 %
Institutions - 12.48 %
Public - 17.30 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
